LIP
TEVA icon

Lighthouse Investment Partners’s Teva Pharmaceuticals TEVA Stock Holding History

Lighthouse Investment Partners’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-120,000
Closed -$2.16M – 640
2024
Q3 		$2.16M Buy
+120,000
New +$2.1M 0.08% 244

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Lighthouse Investment Partners's TEVA Position: Q4 2025 in Review

Lighthouse Investment Partners sold out of Teva Pharmaceuticals (TEVA) in Q4 2025, closing a stake of 45,000 shares — an estimated $909K sold.

Lighthouse Investment Partners first reported a position in TEVA in Q2 2024 and held it in 5 quarters. The position peaked at $6.83M in Q2 2024. 631 funds tracked by Wall St. Rank hold TEVA as of Q4 2025.

  • Lighthouse Investment Partners reported no remaining Teva Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Lighthouse Investment Partners sold 45,000 Teva Pharmaceuticals shares in Q4 2025, an estimated $909K.
  • Lighthouse Investment Partners first reported a position in Teva Pharmaceuticals in Q2 2024 and held it in 5 quarters.
  • Lighthouse Investment Partners's Teva Pharmaceuticals position peaked at $6.83M in Q2 2024.
  • 631 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2025.

Based on Lighthouse Investment Partners's 13F filing for Q4 2025, filed 17 Feb 2026.